Could they be the next “eye” phone? I spoke with the founders of Xpanceo to find out.

NHS England’s South East region is rolling out an AI that can discharge patients with harmless skin lesions without a dermatologist seeing them. DERM, made by London-based Skin Analytics, goes live in all 18 NHS trusts there from this autumn. It will c…

Paris start-up Rivercell has raised a $25M seed round to build an AI model that predicts how human cells respond to drugs and genetic changes. HV led the round, with HCVC, Alven and Bpifrance Digital Venture taking part, the company said on Wednesday. …

A European research group has built a robot that uses magnets to steer ultra-thin graphene electrodes into the brain. Barcelona’s INBRAIN Neuroelectronics, which leads the clinical work, announced the results on Wednesday, at the end of the EU-funded M…

Bridge Neurotech came out of stealth on Tuesday with $13.5M in funding. It plans a brain-computer interface that needs no surgery and no implant. The startup wants to use ultrasound to read brain activity through the skull. It also signed a research de…

Karl Deisseroth, Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine. The prize rewards optogenetics, a method that switches nerve cells on and off with light. The Nobel Assembly at Karolinska Institutet in Stockholm …

Grindr has agreed to buy PurposeMed, the company behind HIV prevention service Freddie, for $250mn in cash and stock, it said in a statement on Wednesday. Grindr will pay $190mn in cash and $60mn in shares. Up to $70mn more in cash depends on Freddie h…

Google DeepMind has brought its SynthID watermarking technology to synthetic biology. The new tool, SynthID Bio, hides a signature in the amino acid sequence or predicted 3D structure of a protein. The lab announced it on Wednesday in a blog post and a…